Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 3

Sponsor Class

INDUSTRY 3NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Sarcoma 1

Conditions

Sarcoma 9Ovarian Neoplasms 6Neoplasms 6Liposarcoma 4Neoplasm Metastasis 3Leiomyosarcoma 3Breast Neoplasms 3Neoplasms by Site 2Uterine Neoplasms 1Skin Diseases 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Ovarian Diseases 1Neoplasms, Connective and Soft Tissue 1Neoplasms by Histologic Type 1Mesothelioma, Malignant 1Liver Diseases 1Liposarcoma, Myxoid 1Hepatic Insufficiency 1Genital Diseases, Female 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Endocrine Gland Neoplasms 1Carcinoma 1Breast Diseases 1Adnexal Diseases 1

Interventions

pembrolizumab 98Gemcitabine 70Paclitaxel 59Docetaxel 52Carboplatin 49Cisplatin 40Nivolumab 39Capecitabine 35Pemetrexed 33Fluorouracil 32Bevacizumab 32Cetuximab 31130-nm albumin-bound paclitaxel 28Trastuzumab 26Irinotecan 24Albumin-Bound Paclitaxel 24Fulvestrant 22Leucovorin 20Oxaliplatin 18Panitumumab 17abemaciclib 16Ipilimumab 16Cyclophosphamide 15cemiplimab 14atezolizumab 14Letrozole 14palbociclib 12Lapatinib 12Drug Therapy 12Doxorubicin 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Neoplasm Metastasis × Trabectedin × Clear all
NCT01273493 2016-02-15

A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

Janssen Research & Development, LLC

Phase 1 Completed
15 enrolled

Liver Diseases, Neoplasm Metastasis, Hepatic Insufficiency

NCT01267084 2015-10-14

A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

Janssen Research & Development, LLC

Phase 1/2 Completed
12 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT00060944 2014-09-08

A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 2 Completed
271 enrolled 13 charts
Sarcoma

Leiomyosarcoma, Liposarcoma, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡